Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

Share Price is delayed by 15 minutes
Get Live Data
2,494.00    24.00 (0.97%)
Bid:
2,484.00
Ask:
2,488.00
Spread: 4.00 (0.161%)
Market Cap: £8.01b
BNZL Live PriceLast checked at - London Stock Exchange

Intraday Bunzl Share Chart

Trading Statement

16 Dec 2020 07:00

RNS Number : 7724I
Bunzl PLC
16 December 2020
 

16 December 2020

 

BUNZL PRE-CLOSE STATEMENT AND ACQUISITION IN CANADA

 

Bunzl plc, the specialist international distribution and services Group, is updating the market today prior to entering its closed period for the year ending 31 December 2020.

 

The Group's resilient business model is expected to deliver a strong performance in the year ending 31 December 2020, with continued growth in Covid-19 related orders during the fourth quarter of the year against the background of increased pandemic-driven restrictions in some markets.

 

Group revenue for the year is expected to increase by approximately 8% at actual exchange rates and by approximately 9% at constant exchange rates, due to similar levels of growth from both the increase in organic revenue and the impact of acquisitions. Organic revenue growth continues to reflect diverging trends between the strength of Covid-19 related product sales, including a higher proportion of imported own brand products such as gloves, masks, sanitisers and disinfectants, and declines in the sales of other products. The Group expects the growth in Covid-19 related sales over the fourth quarter to be driven by the ongoing support of smaller orders, whilst larger orders will continue to slow. The decline in other product sales seen earlier in the year is expected to improve slightly despite the impact of recently strengthened pandemic-related restrictions in some markets. The Group operating margin in 2020 has continued to benefit significantly from the mix of products sold and is expected to be higher than the prior year.

 

Looking ahead, visibility remains limited on the future extent and duration of pandemic-related restrictions, the timing of the roll-out of vaccination programmes and the pandemic's macroeconomic impact. At constant exchange rates the Group expects revenue in 2021 to be lower than the current year with minimal benefit from larger Covid-19 related orders which have strongly supported the performance in 2020. The Group expects an underlying recovery in sales of other products to be broadly offset by a decline in smaller Covid-19 related orders, with acquisitions made during 2020 making a contribution to the Group's performance in 2021. Group operating margins are expected to return to more historical levels.

 

The Company also announces that it has recently completed the purchase of Snelling, a Canadian business focused on the sale of cleaning and hygiene products and industrial and foodservice packaging with revenue in 2019 of C$48 million (c.£28 million). Snelling principally supplies customers operating in the grocery, industrial and hospitality sectors throughout Eastern and Central Canada. In addition, further to the announcement on 9 November 2020, the Company also confirms that it has now completed the acquisition of SP Equipamentos, a leading personal protection equipment distributor based in Sao Paulo, Brazil, with revenue in 2019 of BRL143 million (c.£22 million).

 

 

Commenting on today's announcement, Frank van Zanten, Chief Executive Officer of Bunzl, said:

 

"The Group's performance during the pandemic has demonstrated the resilience of the Bunzl portfolio, the strength of our supply chain and the agility of our decentralised operating model. Growth through acquisitions continues to be an important part of our strategy and the new acquisitions demonstrate our continued success in attracting high quality businesses to join Bunzl. This year has been one of the most acquisitive in our history, with more than £410 million of committed spend. The acquisition pipeline remains active with a number of discussions ongoing."

 

 

 

Enquiries:

 

Bunzl plc

Frank van Zanten, Chief Executive Officer

Richard Howes, Chief Financial Officer

Tel: +44 (0)20 7725 5000

Tulchan

David Allchurch

Martin Robinson

Tel: +44 (0)20 7353 4200

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBIBDDRDBDGGU
Date   Source Headline
14th Jun 20195:30 pmRNSDirector/PDMR Shareholding
12th Jun 20195:15 pmRNSDirector/PDMR Shareholding
5th Jun 20191:00 pmRNSDirector/PDMR Shareholding
3rd Jun 20198:00 amRNSTotal Voting Rights
28th May 20197:00 amRNSDirectorate Change
21st May 20194:30 pmRNSDirector/PDMR Shareholding
21st May 20198:00 amRNSAdditional Listing
14th May 20198:00 amRNSAdditional Listing
10th May 20193:30 pmRNSHolding(s) in Company
10th May 20197:00 amRNSDirectorate Change
3rd May 20194:20 pmRNSDirector/PDMR Shareholding
1st May 20193:00 pmRNSBlock listing Interim Review
1st May 201910:20 amRNSTotal Voting Rights
18th Apr 20193:15 pmRNSHolding(s) in Company
17th Apr 20194:00 pmRNSResult of AGM
17th Apr 20197:00 amRNSTrading Statement
11th Apr 20195:25 pmRNSDirector/PDMR Shareholding
3rd Apr 20195:00 pmRNSDirector/PDMR Shareholding
1st Apr 20194:15 pmRNSDirector/PDMR Shareholding
1st Apr 20193:37 pmRNSHolding(s) in Company
1st Apr 20192:30 pmRNSTotal Voting Rights
29th Mar 201911:30 amRNSDirector/PDMR Shareholding
25th Mar 20192:37 pmRNSHolding(s) in Company
14th Mar 20194:40 pmRNSAnnual Financial Report
14th Mar 201912:30 pmRNSDirector/PDMR Shareholding
11th Mar 20195:30 pmRNSDirector/PDMR Shareholding
7th Mar 20195:00 pmRNSDirector/PDMR Shareholding
5th Mar 20194:30 pmRNSDirector/PDMR Shareholding
4th Mar 20195:45 pmRNSDirector/PDMR Shareholding
4th Mar 20195:45 pmRNSDirector/PDMR Shareholding
1st Mar 20193:00 pmRNSDirector/PDMR Shareholding
1st Mar 201911:00 amRNSTotal Voting Rights
25th Feb 201910:00 amRNSDividend Declaration
25th Feb 20197:00 amRNSFinal Results
25th Feb 20197:00 amRNSAcquisition
4th Feb 20196:00 pmRNSDirector/PDMR Shareholding
1st Feb 20199:00 amRNSTotal Voting Rights
9th Jan 20194:30 pmRNSDirector/PDMR Shareholding
3rd Jan 20195:15 pmRNSDirector/PDMR Shareholding
3rd Jan 20197:00 amRNSTotal Voting Rights
13th Dec 20187:00 amRNSTrading Statement
6th Dec 201810:00 amRNSDirector/PDMR Shareholding
6th Dec 20187:00 amRNSDirectorate Change
4th Dec 20184:15 pmRNSDirector/PDMR Shareholding
4th Dec 201812:15 pmRNSDirector/PDMR Shareholding
3rd Dec 20187:00 amRNSTotal Voting Rights
28th Nov 20184:50 pmRNSDirector/PDMR Shareholding
26th Nov 20188:00 amRNSAdditional Listing
9th Nov 20185:52 pmRNSHolding(s) in Company
2nd Nov 20183:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.